Limbus AI
Healthcare Software · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2076 Athol St, Regina, Saskatchewan, S4T...Phone Number
(306) 502-5982Website
www.limbus.aiRevenue
<$5 MillionIndustry
About Limbus AI
Limbus AI specializes in automated contouring software for radiation therapy, providing clinical-grade contours that enhance the efficiency of treatment planning. Their solution integrates seamlessly with existing systems, ensuring patient data remains secure and local. The software is designed for healthcare professionals in oncology, aiming to reduce contouring time significantly while maintaining high accuracy. With a comprehensive library of anatomical structures and a focus on continuous improvement, Limbus AI supports clinics in delivering timely and effective cancer care.Explore more
Limbus AI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Limbus AI
Compare insights from companies similar to Limbus AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Limbus AI Tech Stack
A closer look at the technologies used by Limbus AI
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Limbus AI
Sign Up For FreeTo access detailed company insights
Limbus AI specializes in automated contouring software for radiation therapy, providing clinical-grade contours that enhance the efficiency of treatment planning. Their solution integrates seamlessly with existing systems, ensuring patient data remains secure and local. The software is designed for healthcare professionals in oncology, aiming to re... Read More
